BRIEF — United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation — SEC Filing

Oct 14 (Reuters) — United Therapeutics Corporation: United Therapeutics Corp - Enters Settlement Agreement With Liquidia To Resolve Litigation - Sec Filing United Therapeutics Corp - Liquidia To Pay United Therapeutics $330.40 Million Under Settlement Agreement - Sec Filing United Therapeutics Corp - Parties To Seek Dismissal Of Litigation Within Ten Days After $185 Million Payment - Sec Filing United Therapeutics Corp - Liquidia To Cease Sales Of Yutrepia With Ph-ild Indication Upon Fda Approval - Sec Filing United Therapeutics Corp - Liquidia To Market Yutrepia Only To Practitioners Treating Pah - Sec Filing United Therapeutics Corp - Liquidia To Terminate Ascent Trial Cohorts Studying Ph-ild And Cease Data Publication - Sec Filing Source text:... Further company coverage: UTHR.O (Reuters.Briefs@thomsonreuters.com;)